Welcome to our website for a research study of an investigational antiviral treatment for people ages 18 to 64 with mild or moderate COVID-19.

This research study is evaluating an investigational antiviral treatment to see if it can treat COVID-19 infections.

This is not a vaccine study. This study is being conducted to investigate the safety, tolerability, and potential benefit of an investigational antiviral treatment called zotatifin when given to people with COVID-19. Zotatifin may inhibit the SARS-CoV-2 virus that causes COVID-19.

If you think you might have gotten COVID-19 within the last 3-4 days or have tested positive (not required) for COVID-19 in the past 24 hours, please complete our pre-qualifying questionnaire to see if you may qualify to participate in our study.

Do you think you might have COVID-19 or have you tested positive for COVID-19 in the past 24 hours? Answer “yes” if either or both statements are true. Answer “no” if both statements are false.
 
Yes
No
Are you 18 to 64 years of age?
 
Yes
No
How did you hear about this research study?
 
Please enter your home or work zip code. This zip code will be used to locate a study center near you. Please provide the zip code that would be most convenient to you.
 
Enter 5-digit zip code
Which of the following COVID-19 symptoms do you currently have that started no more than 3-4 days ago?
 
Fever or chills
Cough
Shortness of breath or
difficulty breathing on
exertion
Fatigue
Muscle or body aches
Headache
New loss of taste or smell
Congestion or runny nose
Nausea or vomiting
Diarrhea
None of these apply




By clicking you authorize us to proceed with the pre-screening process and to begin recording your answers. By clicking you also consent to the terms of the Privacy Policy. Your name and contact information will not be associated with your answers unless you provide this information after you complete the pre-qualifying questionnaire.

Who should complete the pre-qualifying questionnaire?

Any adult age 18 to 64 with mild or moderate COVID-19.

What if I am helping a person fill out the pre-qualifying questionnaire?

These questions are directed to the person who will participate in the research study if they qualify, so "you" as used in the pre-qualifying questionnaire refers to that person.

Is there an obligation to continue if I complete the pre-qualifying questionnaire?

No. You may take the pre-qualifying questionnaire just to see if you might pre-qualify. Participation in a research study is completely voluntary at every step in the process.

Why Is This Research Study Important?

Thank you for your interest in joining the growing number of people who have done their part to help the medical community address the COVID-19 pandemic by participating in a research study, also called a clinical trial.

Current management of COVID-19 infections focuses on treating the symptoms. Research studies that seek to find new treatments for COVID-19 are very important. Before new treatments can be approved for public use, they must be tested in research studies like this one.


Click here to learn more about this important study.


Participating Cities



  • Florida
    •  Bradenton
    •  Miami Lakes
    •  Tampa
  • Maryland
    •  Bethesda


What is Clinical Research?

Although there are many definitions, a clinical research study is generally considered to be health-related clinical research in people with a specific condition using a pre-defined written protocol.

Click here to learn more about clinical research.

Welcome to our website for a research study of an investigational antiviral treatment for people ages 18 to 64 with mild or moderate COVID-19.


Navigation Powered by The Patient Recruiting Agency ™
© TPRA, 2021
Privacy and Confidentiality Policy

A copy of the Data Protection and Privacy Policy for this website is available at this location: Data Protection and Privacy Policy http://tprausa.com/privacy/